CIK 0000886163 · Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770160744
- Phone
- 858-550-7500
- Business address
- 3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $6,585,411
- in 7 filings, $4.5M under 10b5-1 plans
Net −$6,585,411. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-03 | Reardon Andrew CLO & Secretary | Sale 10b5-1 | −157 | $285.74 | $45K | 46,219 |
| 2026-08-03 | Reardon Andrew CLO & Secretary | Sale 10b5-1 | −1,032 | $286.80 | $296K | 45,187 |
| 2026-08-03 | Reardon Andrew CLO & Secretary | Sale 10b5-1 | −1,214 | $287.77 | $349K | 43,973 |
| 2026-08-03 | Reardon Andrew CLO & Secretary | Sale 10b5-1 | −356 | $288.75 | $103K | 43,617 |
| 2026-08-03 | Reardon Andrew CLO & Secretary | Sale 10b5-1 | −503 | $289.80 | $146K | 43,114 |
| 2026-08-03 | Reardon Andrew CLO & Secretary | Sale 10b5-1 | −200 | $290.60 | $58K | 42,914 |
| 2026-08-03 | Reardon Andrew CLO & Secretary | Sale 10b5-1 | −991 | $291.71 | $289K | 41,923 |
| 2026-08-03 | Reardon Andrew CLO & Secretary | Sale 10b5-1 | −409 | $292.82 | $120K | 41,514 |
| 2026-08-03 | Reardon Andrew CLO & Secretary | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −5,000 | 29,444 | ||
| 2026-07-01 | Reardon Andrew CLO & Secretary | Option exercise 10b5-1 | +5,000 | $52.27 | $261K | 46,514 |
| 2026-07-01 | Reardon Andrew CLO & Secretary | Sale 10b5-1 | −396 | $308.99 | $122K | 46,118 |
| 2026-07-01 | Reardon Andrew CLO & Secretary | Sale 10b5-1 | −104 | $310.20 | $32K | 46,014 |
| 2026-07-01 | Reardon Andrew CLO & Secretary | Sale 10b5-1 | −1,119 | $311.72 | $349K | 44,895 |
| 2026-07-01 | Reardon Andrew CLO & Secretary | Sale 10b5-1 | −1,081 | $312.28 | $338K | 43,814 |
| 2026-07-01 | Reardon Andrew CLO & Secretary | Sale 10b5-1 | −700 | $313.46 | $219K | 43,114 |
| 2026-07-01 | Reardon Andrew CLO & Secretary | Sale 10b5-1 | −100 | $314.58 | $31K | 43,014 |
| 2026-07-01 | Reardon Andrew CLO & Secretary | Sale 10b5-1 | −900 | $315.78 | $284K | 42,114 |
| 2026-07-01 | Reardon Andrew CLO & Secretary | Sale 10b5-1 | −600 | $317.15 | $190K | 41,514 |
| 2026-07-01 | Reardon Andrew CLO & Secretary | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −5,000 | 34,444 | ||
| 2026-06-30 | Reardon Andrew CLO & Secretary | Other acquisition 10b5-1 | +132 | $160.71 | $21K | 41,514 |
Page 4 of 43 · 858 trades